QUESTION LIST
Get names.
Ask for reasons.
Bring these questions to an in-person visit or telehealth: care through video, phone calls or online messages. Write down the answers before agreeing to a plan.
Get the details before committing
- The full name and job of the person who will decide about treatment
- The pharmacy that makes and sends the medicine
- How to get answers to questions once the visit is over
Check who can treat you
The person providing telehealth care needs a licence or state permission covering the state where you are for that visit, as of September 26, 2026.
A state medical board licenses doctors and makes their licence records public, along with any penalties it has disclosed.
A licence record that lists no public penalty cannot show how well a doctor provides care.
- Who will decide about treatment? What is their full name?
- What is their job: doctor, nurse or another health professional?
- Which licence or state permission covers my visit?
- If it is another permission, what is its name, and where can I check it with the state?
Open the licence-check tools
Look for a review of your health
Picking a treatment off a menu before anyone reviews your health is not proper care, according to the national group of state medical boards in guidance checked September 26, 2026.
Each state decides its own rules; this national advice is not itself a law.
A form may be used during a visit, but the medical boards’ advice says you and the person providing care must both be able to ask further questions.
- What else might explain my symptoms?
- Why consider sermorelin for my goal?
- What are the other options, including no drug?
- Will any tests or an in-person exam be needed?
Read the medical boards’ guidance
Check the pharmacy by name
Ask for the pharmacy’s actual name, then check it with your state’s board of pharmacy, the body that licenses pharmacies.
As of September 26, 2026, most states require a pharmacy based in another state to have your state’s licence or permit before sending you medicine.
Compounding is the process of making medicine to order.
Sermorelin acetate is the full ingredient name in the old approved drug, according to records checked September 28, 2026.
- Who prepares the medicine, and who handles sending it to me?
- Which records can I check for that pharmacy?
- Is the ingredient sermorelin acetate?
- What instructions come with it for storage and handling?
State pharmacy licence search tools are linked from the Food and Drug Administration (FDA) website.
Open the pharmacy licence search
Get a plan for follow-up
Older studies most often reported brief warmth or redness in the face, and pain at the spot where the needle went in.
These old studies, mostly in children, do not tell us how often adults might have side effects with today’s made-to-order medicine.
There is no current FDA-reviewed sermorelin label with safety instructions about who must avoid it or its use during pregnancy, as of September 28, 2026.
- How will we judge whether this helps?
- When will we review the plan?
- Who answers if I notice a problem?
- How does my health history change the decision?
Open the sources on reported effects
PAUSE AND CHECK
An offer that skips the basics
Medicine without a prescription
As of September 26, 2026, federal law says prescription medicine may be supplied only with a valid prescription.
“FDA registered” presented as approval
FDA registration means the agency has a facility on record. That record does not show FDA approval for the facility or its medicines, as of September 26, 2026.
“For research use only” offered as treatment
A seller may offer a product for use by people while its label says “for research use only”.
FDA warning letters called products sold that way unapproved drugs, as of September 26, 2026.
A warning letter says what the FDA believes a seller did wrong; it is not a court ruling.